Lanreotide Subcutaneous and Omeprazole Delayed-Release Capsules
Determining the interaction of Lanreotide Subcutaneous and Omeprazole Delayed-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: omeprazole
Brand name: FIRST Omeprazole, Omeprazole + SyrSpend SF Alka, Prilosec, Prilosec OTC, Zegerid>, Prilosec, Prilosec OTC
Synonyms: Omeprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-Omeprazole Delayed-Release Capsules and Tablets (OTC)
- Lanreotide Subcutaneous-Omeprazole Orally-Disintegrating Tablets
- Lanreotide Subcutaneous-Omeprazole Powder for Oral Suspension
- Lanreotide Subcutaneous-Omeprazole Tablets
- Lanreotide Subcutaneous-Omeprazole, Clarithromycin, and Amoxicillin
- Lanreotide Subcutaneous-Omidria
- Omeprazole Delayed-Release Capsules-Lansoprazole
- Omeprazole Delayed-Release Capsules-Lansoprazole Delayed-Release Capsules
- Omeprazole Delayed-Release Capsules-Lansoprazole Orally Disintegrating Tablets
- Omeprazole Delayed-Release Capsules-Lansoprazole, Amoxicillin, and Clarithromycin
- Omeprazole Delayed-Release Capsules-Lanthanum
- Omeprazole Delayed-Release Capsules-Lanthanum carbonate